Sirolimus Use in Angioplasty for Vascular Access Extension (SAVE)
A Randomized Open Label Trial of Oral Sirolimus for Decrease of Stenosis in Arteriovenous Fistula in Hemo-dialysis Patients When Compared With Standard Therapy
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
This PHASE2 trial investigates End Stage Renal Disease and Venous Stenosis and is currently completed. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE2
-
Jan 2025 — Apr 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jun 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Jun 2022 [monthly]
Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .